Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 17 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• APG-2449 in Patients With Advanced Solid TumorsRecruitingNCT03917043Phase 1
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung CancerRecruitingNCT03908671Not applicable
• Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 1
• Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseaseRecruitingNCT03808337Phase 2
• Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer PatientsRecruitingNCT03803787Phase 2
• A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid TumorsRecruitingNCT03797391Phase 1/2
• Cell Free DNA for the Diagnosis and Treatment in Early NSCLCRecruitingNCT03791034
• ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)RecruitingNCT03786003Not applicable
• TCR-T Cell Immunotherapy of Lung Cancer and Other Solid TumorsRecruitingNCT03778814Phase 1
• Biomarkers for Risk Stratification in Lung CancerRecruitingNCT03774758
• Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLCRecruitingNCT03769129Not applicable
• Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLCRecruitingNCT03742687Not applicable
• Genomic Investigation of Unusual RespondersRecruitingNCT03740503
• Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung CancerRecruitingNCT03647592
• Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung CancerRecruitingNCT03647111
• Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung CancerRecruitingNCT03646994
• Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save StudyRecruitingNCT03646968Phase 2
• NSCLC Isotoxic Hypofractionated RadiotherapyRecruitingNCT03606291Not applicable
• NSCLC Isotoxic Hypofractionated ChemoradiotherapyRecruitingNCT03606239Not applicable
• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
• Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowRecruitingNCT03551951
• Vapor Ablation for Localized Cancer LesionsNot yet recruitingNCT03514329Not applicable
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerRecruitingNCT03412877Phase 2
• Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite TumorsRecruitingNCT03392233Phase 2
• Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
• Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)RecruitingNCT03334864
• Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerRecruitingNCT03199651Not applicable
• Study of High Efficient Killing Cell Therapy for Advanced NSCLCRecruitingNCT03193567Phase 1
• Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangeRecruitingNCT03191149Phase 2
• Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorRecruitingNCT03093688Phase 1/2
• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsRecruitingNCT03093116Phase 1/2
• Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI TherapyRecruitingNCT03042221
• Veterans Affairs Lung Cancer Surgery Or Stereotactic RadiotherapyRecruitingNCT02984761Not applicable
• A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung CancerRecruitingNCT02889666Phase 1
• Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruitingNCT02838836
• Plasmodium Immunotherapy for Lung CancerRecruitingNCT02786589Phase 1/2
• CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung CancerRecruitingNCT02764606
• Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung CancerRecruitingNCT02731001Not applicable
• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsRecruitingNCT02682667
• Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma PatientsRecruitingNCT02622581
• Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLCRecruitingNCT02619448Early Phase 1
• Couple-Based Meditation for Metastatic Lung Cancer Patients and Their PartnersRecruitingNCT02596490Not applicable
• Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung CancerRecruitingNCT02570815Phase 1
• LIquid BIopsies in Patients Presenting Non-small Cell Lung CancerRecruitingNCT02511288
• JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerRecruitingNCT02468024Phase 3
• Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung CancerRecruitingNCT02448992Phase 2/3
• Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial TumorsRecruitingNCT02146170
• T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerRecruitingNCT02133196Phase 2
• Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung CancersRecruitingNCT02098954Phase 2
• A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients TreatmentRecruitingNCT01994057
• Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung CancersRecruitingNCT01871454Phase 2
• Stereotactic Radiotherapy (SBRT) of Lung MetastasisRecruitingNCT01803542Phase 2
• Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung CancerRecruitingNCT01720836Phase 1/2
• Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityRecruitingNCT01639508Phase 2
• Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyNot yet recruitingNCT01595074
• Molecular Analysis of Thoracic MalignanciesEnrolling by invitationNCT01385722
• Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersRecruitingNCT00900419
• Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerRecruitingNCT00897117
• The Effect of Beta-glucan in Non-Small Cell Lung CancerRecruitingNCT00682032Not applicable
• DNA Analysis of Blood and Tissue From Patients With Lung CancerRecruitingNCT00471978
• Lung Cancer Biomarkers and ScreeningRecruitingNCT00301119
• Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior ChemotherapyRecruitingNCT00100256Phase 1/2
• Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT00068003
• A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be ControlledCompletedNCT06282991Results posted
• A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based ChemotherapyTerminatedNCT06267001Phase 3Results posted
• A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan ExtensionActive, not recruitingNCT06212752Phase 3Results posted
• A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)Active, not recruitingNCT06099782Phase 2Results posted
• Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung CancerTerminatedNCT06048705Phase 1Results posted
• A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C MutationTerminatedNCT06039384Phase 1Results posted
• A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung CancerCompletedNCT06029127Phase 2Results posted
• A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid TumorsTerminatedNCT06024174Phase 1/2Results posted
• Induction Chemo-Nivo in Unresectable Stage III NSCLCTerminatedNCT06003075Phase 2Results posted
• Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCCTerminatedNCT05846646Phase 2Results posted
• A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.CompletedNCT05834348Results posted
• A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung CancerCompletedNCT05775289Phase 2Results posted
• A Study of TAS3351 in NSCLC Patients With EGFRmtTerminatedNCT05765734Phase 1Results posted
• Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain MetastasesTerminatedNCT05746481Phase 2Results posted
• A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)Active, not recruitingNCT05722015Phase 3Results posted
• NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursTerminatedNCT05714553Phase 1/2Results posted
• Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLCTerminatedNCT05691829Phase 2Results posted
• Premedication to Reduce Amivantamab Associated Infusion Related ReactionsActive, not recruitingNCT05663866Phase 2Results posted
• Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung CancerTerminatedNCT05617313Phase 2Results posted
• A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)TerminatedNCT05577715Phase 2Results posted
• Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung CancerCompletedNCT05577702Phase 2Results posted
• A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsTerminatedNCT05551117Phase 2Results posted
• Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15CompletedNCT05546476Phase 2Results posted
• A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung CancerTerminatedNCT05543629Phase 1/2Results posted
• A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT05513703Phase 2Results posted
• A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 GeneTerminatedNCT05469178Phase 1/2Results posted
• A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)Active, not recruitingNCT05460273Phase 1/2Results posted
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTerminatedNCT05451849Phase 1/2Results posted
• Postoperative Telerehabilitation in Older AdultsCompletedNCT05435885Not applicableResults posted
• A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursTerminatedNCT05397171Phase 1/2Results posted
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung CancerActive, not recruitingNCT05388669Phase 3Results posted
• VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung CancerTerminatedNCT05374538Phase 1Results posted
• Tarlox and Sotorasib in Patients With KRAS G12C MutationsTerminatedNCT05313009Phase 1/2Results posted
• A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung CancerTerminatedNCT05275673Phase 2Results posted
• A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201)TerminatedNCT05267470Phase 1Results posted

← Carcinoma, Non-Small-Cell Lung overview